Following an outlicensing agreement with SATT Nord, a public entity managing intellectual property for the University of Reims Champagne-Ardenne (URCA), VG2D now holds full rights to exploit the molecule. The molecule, invented by Dr. Velard and Prof. Gerard during their tenure at URCA, was initially under the university’s ownership.
News
VG2D Pharma was on the front page of the regional magazine Grand Est
The VG2D Pharma team shared their ambitious vision for health equity with Grand Est, highlighting how the company plans to turn their slogan, “Innovation with Broader Reach,” into a tangible
7 January 2025
